Barrow, Hanley, Mewhinney & Strauss’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $119M | Sell |
407,168
-98,371
| -19% | -$32.3M | 0.39% | 74 |
|
|
2025
Q4 | $177M | Buy |
505,539
+8,199
| +2% | +$2.77M | 0.59% | 60 |
|
|
2025
Q3 | $161M | Sell |
497,340
-83,828
| -14% | -$26.1M | 0.51% | 62 |
|
|
2025
Q2 | $226M | Sell |
581,168
-689,426
| -54% | -$277M | 0.76% | 53 |
|
|
2025
Q1 | $553M | Buy |
1,270,594
+487,672
| +62% | +$196M | 2.01% | 11 |
|
|
2024
Q4 | $289M | Sell |
782,922
-67,718
| -8% | -$28.3M | 0.98% | 41 |
|
|
2024
Q3 | $442M | Sell |
850,640
-382,829
| -31% | -$205M | 1.45% | 26 |
|
|
2024
Q2 | $668M | Sell |
1,233,469
-38,447
| -3% | -$20.3M | 2.28% | 8 |
|
|
2024
Q1 | $660M | Sell |
1,271,916
-95,516
| -7% | -$47.5M | 2.22% | 9 |
|
|
2023
Q4 | $645M | Sell |
1,367,432
-3,803
| -0.3% | -$1.76M | 2.27% | 9 |
|
|
2023
Q3 | $597M | Buy |
1,371,235
+132,432
| +11% | +$60.1M | 2.28% | 9 |
|
|
2023
Q2 | $550M | Sell |
1,238,803
-33,823
| -3% | -$15.6M | 2.05% | 12 |
|
|
2023
Q1 | $585M | Sell |
1,272,626
-180,010
| -12% | -$85.7M | 2.26% | 7 |
|
|
2022
Q4 | $745M | Sell |
1,452,636
-54,426
| -4% | -$27.6M | 2.8% | 4 |
|
|
2022
Q3 | $685M | Sell |
1,507,062
-106,153
| -7% | -$50.8M | 2.81% | 4 |
|
|
2022
Q2 | $779M | Sell |
1,613,215
-26,697
| -2% | -$13.2M | 2.94% | 4 |
|
|
2022
Q1 | $806M | Sell |
1,639,912
-111,865
| -6% | -$51.1M | 2.63% | 3 |
|
|
2021
Q4 | $812M | Sell |
1,751,777
-91,021
| -5% | -$38.3M | 2.57% | 2 |
|
|
2021
Q3 | $687M | Buy |
1,842,798
+30,017
| +2% | +$11.4M | 2.28% | 7 |
|
|
2021
Q2 | $692M | Buy |
1,812,781
+163,444
| +10% | +$62.5M | 2.22% | 8 |
|
|
2021
Q1 | $592M | Buy |
1,649,337
+136,537
| +9% | +$43.9M | 1.89% | 13 |
|
|
2020
Q4 | $486M | Sell |
1,512,800
-54,935
| -4% | -$16.9M | 1.67% | 23 |
|
|
2020
Q3 | $421M | Sell |
1,567,735
-41,428
| -3% | -$11.1M | 1.62% | 25 |
|
|
2020
Q2 | $423M | Sell |
1,609,163
-191,020
| -11% | -$51M | 1.66% | 21 |
|
|
2020
Q1 | $409M | Buy |
1,800,183
+88,746
| +5% | +$24.2M | 1.87% | 18 |
|
|
2019
Q4 | $517M | Sell |
1,711,437
-1,905,345
| -53% | -$524M | 1.65% | 23 |
|
|
2019
Q3 | $868M | Sell |
3,616,782
-204,890
| -5% | -$56.1M | 1.7% | 24 |
|
|
2019
Q2 | $1.08B | Buy |
3,821,672
+1,921,814
| +101% | +$525M | 1.96% | 20 |
|
|
2019
Q1 | $545M | Sell |
1,899,858
-143,639
| -7% | -$41.5M | 0.98% | 35 |
|
|
2018
Q4 | $537M | Sell |
2,043,497
-279,693
| -12% | -$76.9M | 1.05% | 34 |
|
|
2018
Q3 | $637M | Sell |
2,323,190
-118,676
| -5% | -$30.8M | 1.01% | 35 |
|
|
2018
Q2 | $581M | Buy |
2,441,866
+19,494
| +0.8% | +$4.51M | 0.94% | 36 |
|
|
2018
Q1 | $532M | Sell |
2,422,372
-53,255
| -2% | -$12.5M | 0.85% | 38 |
|
|
2017
Q4 | $557M | Sell |
2,475,627
-105,011
| -4% | -$22.4M | 0.83% | 38 |
|
|
2017
Q3 | $490M | Sell |
2,580,638
-4,064,665
| -61% | -$774M | 0.74% | 40 |
|
|
2017
Q2 | $1.25B | Sell |
6,645,303
-891,661
| -12% | -$160M | 1.9% | 22 |
|
|
2017
Q1 | $1.25B | Sell |
7,536,964
-516,064
| -6% | -$82.1M | 1.88% | 21 |
|
|
2016
Q4 | $1.16B | Sell |
8,053,028
-361,879
| -4% | -$48.5M | 1.74% | 26 |
|
|
2016
Q3 | $1.05B | Sell |
8,414,907
-160,604
| -2% | -$20.7M | 1.61% | 28 |
|
|
2016
Q2 | $1.13B | Buy |
8,575,511
+1,306,670
| +18% | +$179M | 1.72% | 26 |
|
|
2016
Q1 | $1.01B | Sell |
7,268,841
-130,852
| -2% | -$17.5M | 1.54% | 27 |
|
|
2015
Q4 | $1.03B | Sell |
7,399,693
-145,444
| -2% | -$20M | 1.54% | 28 |
|
|
2015
Q3 | $1.06B | Sell |
7,545,137
-157,568
| -2% | -$23.7M | 1.62% | 30 |
|
|
2015
Q2 | $1.26B | Sell |
7,702,705
-136,303
| -2% | -$21.8M | 1.72% | 22 |
|
|
2015
Q1 | $1.21B | Sell |
7,839,008
-349,112
| -4% | -$49.7M | 1.64% | 26 |
|
|
2014
Q4 | $1.03B | Sell |
8,188,120
-2,572,810
| -24% | -$318M | 1.38% | 31 |
|
|
2014
Q3 | $1.29B | Sell |
10,760,930
-1,007,086
| -9% | -$116M | 1.75% | 23 |
|
|
2014
Q2 | $1.27B | Sell |
11,768,016
-1,444,750
| -11% | -$149M | 1.7% | 22 |
|
|
2014
Q1 | $1.32B | Sell |
13,212,766
-4,256,044
| -24% | -$385M | 1.88% | 20 |
|
|
2013
Q4 | $1.61B | Buy |
17,468,810
+103,335
| +0.6% | +$9.18M | 2.34% | 11 |
|
|
2013
Q3 | $1.45B | Sell |
17,365,475
-66,778
| -0.4% | -$5.72M | 2.32% | 14 |
|
|
2013
Q2 | $1.43B | Buy |
+17,432,253
| New | +$1.3B | 2.4% | 11 |
|
Other funds holding ELV
VCM
VPM
Barrow, Hanley, Mewhinney & Strauss's ELV Position: Q1 2026 in Review
Barrow, Hanley, Mewhinney & Strauss reduced its Elevance Health (ELV) stake by 19% in Q1 2026, selling an estimated $32.3M and leaving 407,168 shares worth $119M. The position accounts for 0.39% of the portfolio, ranked #74.
Barrow, Hanley, Mewhinney & Strauss first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.61B in Q4 2013. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Barrow, Hanley, Mewhinney & Strauss held 407,168 shares of Elevance Health worth $119M as of Q1 2026.
- Barrow, Hanley, Mewhinney & Strauss sold 98,371 Elevance Health shares in Q1 2026, an estimated $32.3M.
- Elevance Health made up 0.39% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q1 2026, its #74 holding.
- Barrow, Hanley, Mewhinney & Strauss first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Barrow, Hanley, Mewhinney & Strauss's Elevance Health position peaked at $1.61B in Q4 2013.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q1 2026, filed 13 May 2026.